Search the webpage

President, Chief Executive Officer and Director

President, Chief Executive Officer and Director

ABOUT

Dr. Kalesnykas earned his Ph.D. in Neuroscience in 2005 from the University of Kuopio and completed several postdoctoral fellowships studying the pathophysiology of glaucoma and ocular gene therapy. He currently serves as an Adjunct Professor of Experimental Ophthalmology at University of Tampere, Finland.

In 2009, Dr. Kalesnykas was awarded the prestigious position of Finnish Academy Research Fellow, which he held until 2013. He was a visiting researcher at the Wilmer Eye Institute at The Johns Hopkins University from 2010-2011. In 2013, he founded Experimentica Ltd., which under his leadership has grown to become one of the leading preclinical CROs dedicated to drug discovery and development for ophthalmic disorders.

FOLLOW

LATEST NEWS

In vivo imaging in the rat oxygen-induced retinopathy model

Oxygen-induced retinopathy model as an experimental model for retinopathy of prematurity and human ischemic retinopathies ... Read More

Are antioxidants the solution to burning and itchy eyes?

A recently published study in The Ocular Surface journal authored by Experimentica Ltd. in collaboration with researchers from Loyola University ... Read More

A summary of 2018 and a preview of 2019

News
An overview of main activities and advancements at Experimentica Ltd. in 2018 ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!